Françoise Kraeber-Bodere

5PUBLICATIONS
44CO-AUTHORS
Medical mycologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 17, 2026
Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results.

|Mar 27, 2026
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Bastien Jamet, Shamimeh Ahrari, Sonja Zweegman

|Sep 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.

Françoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman

|Mar 03, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.

Vincent Camus, Thierry Molina, Fabienne Desmots

|Apr 04, 2023
The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity.

Fabienne Desmots, Delphine Rossille, Mikael Roussel

Pageof 1

Frequent Collaborators

3 joint publications

Emmanuel Itti

3 joint publications

Jill Corre

3 joint publications

Xavier P Leleu

3 joint publications

Caroline Bodet-Milin